PRKAA2 and cancer: Metformin, an antidiabetic drug, can also be used to prevent cancer alone and in combination with other drugs, mainly by reducing glycemia to cut-off the PI3K/MAPK pathway, which is involved in cell growth, or by activating the AMPK pathway, targeting tumor metabolism angiogenesis, cancer stem cells, and other pathways [49].